Sensorineural Hearing Loss Screening
In collaboration with Dr. Ko Tsang-Ming’s lab, Phalanx Biotech developed a test covering more than 90% of the four common hearing impairment-related genes and 361 alleles. It is used with conventional physical examination to provide parents with a more complete result.
Sensorineural Hearing Loss Screening
In collaboration with Dr. Ko Tsang-Ming’s lab, Phalanx Biotech developed a test covering more than 90% of the four common hearing impairment-related genes and 361 alleles. It is used with conventional physical examination to provide parents with a more complete result.
The importance of Sensorineural Hearing Loss Screening
Hearing impairment is the most common congenital defect in newborns. Hearing plays a crucial part in the cognitive and language development of babies. Congenital hearing impairment is also a key factor of language learning, social communication and intellectual development.
Tested loci
Children with hearing impairment
Congenital hearing impairment Common predisposing gene of sensory hearing impairment
Phalanx Biotech’s “Sensorineural Hearing Loss Screening” covers more than 90% of common mutated loci related to hearing (up to 361), while other providers offering an average of 6 loci. Phalanx Biotech is able to provide more complete hearing gene screening.
Indications
- All newborns
- Concerned of neonatal hearing impairment
- Newborns from a family of two or more diagnosed with sensory hearing impairment
Screening procedure
- 1Genetic consultation and education
- 2Writing informed consent for neonatal gene screening
- 3Collect blood sample from the newborn’s heel
- 4Gene analysis report
華聯生技以創新、品質、服務為經營理念，提供全面性的晶片服務
對產品有任何問題皆歡迎提出，我們會盡快與您聯繫！
或洽詢服務專線+886-3-578-1168；0800-777988(按0)，由專人為您提供諮詢！